Snapshot from Jul 07, 2026 at 01:18 UTC. For live data and tracking: View Live
Entities / Merck & Co. / Regeneron Pharmaceuticals

Merck & Co. & Regeneron Pharmaceuticals

1 shared events · Importance 3 · Last updated Jun 03, 2026

Importance
3
Shared Events
1
Actions
0
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the Ergen Dashboard
Shared Events (1)
67
Regulatory
Trump Secures Drug Price Deals
Merck & Co.: Merck & Co. struck a deal to cut prices, committing to sell its diabetes drugs Januvia, Janumet, and Janumet XR at 70% off list prices directly to US consumers and pledging $70 billion in US R&D and manufacturing investments.
Regeneron Pharmaceuticals: Regeneron Pharmaceuticals is expected to announce a deal with the Donald Trump administration after the holidays.
Dec 19, 2025 · 7 articles
NEWSDESK
Explore this relationship live

Track how Merck & Co. and Regeneron Pharmaceuticals interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.